Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...

Analyst Salveen Richter of Goldman Sachs maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), reducing the price target ...

The latest guidance reduction was the second time in the last six months that the firm has revised its forecast in a negative ...

Goldman Sachs analyst Salveen Richter highlights potential benefits for biopharma from 340B reforms, while Medicaid cuts ...

The latest guidance reduction was the second time in the last six months that the firm has revised its forecast in a negative direction, according to Goldman analyst Salveen Richter. Consequently ...

In a report released yesterday, Courtney Breen from Bernstein maintained a Hold rating on Moderna (MRNA – Research Report), with a price target ...

The S&P500 closed in the red on Friday, after the week saw a massive sell-off of AI-related stocks sparked by worries around ...

While the revised outlook appears feasible, it "leads us to believe MRNA has limited visibility on the revenue stream for the respiratory vaccine business," analyst Salveen Richter wrote ...

HIGH SCHOOL: Before UConn, played for head coach Greg Seamon at the Dresden Monarchs in Germany… Helped lead Dresden to an 11-3 overall record and a 10-2 record in ...